Effects of different dosages of Sodium-Glucose Transporter 2 Inhibitors on lipid levels in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis

BACKGROUND: Type 2 diabetes mellitus is one of the most common chronic diseases, which endangers peoples health and life qualities. Sodium-Glucose Transporter 2 (SGLT2) inhibitors have been widely recognized since their clinical application in blood glucose control. While, dyslipidemia caused by SGL...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Tingyu, Gao, Yang, Zhang, Li, Yang, Ting, Chen, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373585/
https://www.ncbi.nlm.nih.gov/pubmed/32702819
http://dx.doi.org/10.1097/MD.0000000000020735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373585/
https://www.ncbi.nlm.nih.gov/pubmed/32702819
http://dx.doi.org/10.1097/MD.0000000000020735

Ejemplares similares